Abstract
Objectives: Data regarding Helicobacter pylori (Hp) infection frequency in concurrent celiac disease (CD) and type 1 diabetes mellitus (T1DM) (CD + T1DM) are anecdotal. This study aimed to evaluate the association between Hp and concomitant CD + T1DM in children. Methods: In this 2-center, case-control study, children who underwent esophago-gastro-duodenoscopy (EGD) were studied. CD diagnosis was established by favorable histology and serology. Hp infection was confirmed by both histology and the rapid urease test. Patients were divided into 3 groups as CD only (CDo), CD + T1DM, and non-CD children who underwent endoscopy as controls. Results: Among the 1,431 EGDs performed, 783 cases were eligible. Overall, 215 cases had CDo (mean age: 9.12 ± 4.18 years, 58.1% girls), 63 cases had CD + T1DM (mean age: 9.29 ± 4.46 years, 50.8% girls), and 505 cases were controls (mean age: 9.69 ± 4.52 years, 56.6% girls). Hp infection rate was significantly lower in CD + T1DM group (controls: 49.7% vs. CDo: 32.1% vs. CD + T1DM: 20.6%, p < 0.01). After adjustment for age, gender, and socioeconomic status, the Hp infection rate was still significantly low (adjusted odds ratio [aOR]: 1.57, 95% confidence interval (CI): 1.35–1.83, p < 0.01). A difference in Hp infection rate between controls and CDo group (aOR: 1.43, 95% CI: 1.09–2.12, p < 0.05), and between CDo and CD + T1DM (aOR: 0.89, 95% CI: 0.65–1.54, p < 0.05) group was significant. The severity of duodenal lesions and the presence of Hp infection were not correlated in all celiac children (r: 0.113, p > 0.05). Conclusion: The frequency of Hp infection was significantly lower in CD + T1DM children, compared to the CDo group and the controls.
References
1.
Singh
P
, Arora
A
, Strand
TA
, Leffler
DA
, Catassi
C
, Green
PH
, Global prevalence of celiac disease: systematic review and meta-analysis
. Clin Gastroenterol Hepatol
. 2018
;16
(6
):823
–36.e2
.2.
Tuomilehto
J
, Ogle
GD
, Lund-Blix
NA
, Stene
LC
. Update on worldwide trends in occurrence of childhood type 1 diabetes in 2020
. Pediatr Endocrinol Rev
. 2020
;17
(Suppl 1
):198
–209
. .3.
Pham-Short
A
, Donaghue
KC
, Ambler
G
, Phelan
H
, Twigg
S
, Craig
ME
. Screening for celiac disease in type 1 diabetes: a systematic review
. Pediatrics
. 2015
;136
(1
):e170
–6
. .4.
Gutierrez-Achury
J
, Romanos
J
, Bakker
SF
, Kumar
V
, de Haas
EC
, Trynka
G
, Contrasting the genetic background of type 1 diabetes and celiac disease autoimmunity
. Diabetes Care
. 2015
;38
(Suppl 2
):S37
–44
. .5.
Kemppainen
KM
, Lynch
KF
, Liu
E
, Lönnrot
M
, Simell
V
, Briese
T
; TEDDY Study Group
, Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life
. Clin Gastroenterol Hepatol
. 2017
;15
(5
):694
–702.e5
.6.
Myléus
A
, Hernell
O
, Gothefors
L
, Hammarström
ML
, Persson
LÅ
, Stenlund
H
, Early infections are associated with increased risk for celiac disease: an incident case-referent study
. BMC Pediatr
. 2012
;12
:194
. .7.
Rewers
M
, Hyöty
H
, Lernmark
Å
, Hagopian
W
, She
JX
, Schatz
D
, TEDDY Study Group
, The environmental determinants of diabetes in the young (TEDDY) study: 2018 update
. Curr Diab Rep
. 2018
;18
(12
):136
. .8.
Crabtree
JE
, O’Mahony
S
, Wyatt
JI
, Heatley
RV
, Vestey
JP
, Howdle
PD
, Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis
. J Clin Pathol
. 1992
;45
(7
):597
–600
. .9.
Aydogdu
S
, Cakir
M
, Yuksekkaya
HA
, Tumgor
G
, Baran
M
, Arikan
C
, Helicobacter pylori infection in children with celiac disease
. Scand J Gastroenterol
. 2008
;43
(9
):1088
–93
. .10.
Rostami-Nejad
M
, Villanacci
V
, Mashayakhi
R
, Molaei
M
, Bassotti
G
, Zojaji
H
, Celiac disease and Hp infection association in Iran
. Rev Esp Enferm Dig
. 2009
;101
(12
):850
–4
. .11.
Jozefczuk
J
, Bancerz
B
, Walkowiak
M
, Glapa
A
, Nowak
J
, Piescikowska
J
, Prevalence of Helicobacter pylori infection in pediatric celiac disease
. Eur Rev Med Pharmacol Sci
. 2015
;19
(11
):2031
–5
.12.
Colombo
C
, Tomasi
PA
, Meloni
GF
, Marinaro
AM
, Ogana
A
, Meloni
T
. Seroprevalence of Helicobacter pylori in children with type 1 diabetes mellitus in Sardinia
. Diabetes Nutr Metab
. 2002
;15
(2
):91
–5
.13.
Candelli
M
, Rigante
D
, Marietti
G
, Nista
EC
, Crea
F
, Bartolozzi
F
, Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients
. Pediatrics
. 2003
;111
(4 Pt 1
):800
–3
. .14.
Chobot
A
, Bak-Drabik
K
, Skała-Zamorowska
E
, Krzywicka
A
, Kwiecień
J
, Polańska
J
. Helicobacter pylori infection in type 1 diabetes children and adolescents using 13C urea breath test
. Pol J Microbiol
. 2014
;63
(1
):63
–7
. .15.
Osman
SM
, Mubarak
SM
, Omer
IM
, Abdullah
MA
. Helicobacter pylori infection and the onset of type 1 diabetes mellitus in Sudanese children
. Sudan J Paediatr
. 2016
;16
(2
):59
–66
.16.
Bayrak
NA
, Tutar
E
, Volkan
B
, Sahin Akkelle
B
, Polat
E
, Kutluk
G
, Helicobacter pylori infection in children with celiac disease: multi-center, cross-sectional study
. Helicobacter
. 2020
;25
(3
):e12691
. .17.
Lebwohl
B
, Blaser
MJ
, Ludvigsson
JF
, Green
PH
, Rundle
A
, Sonnenberg
A
, Decreased risk of celiac disease in patients with Helicobacter pylori colonization
. Am J Epidemiol
. 2013
;178
(12
):1721
–30
. .18.
Lasa
J
, Zubiaurre
I
, Dima
G
, Peralta
D
, Soifer
L
. Helicobacter Pylori prevalence in patients with celiac disease: results from a cross-sectional study
. Arq Gastroenterol
. 2015
;52
(2
):139
–42
. .19.
Narang
M
, Puri
AS
, Sachdeva
S
, Singh
J
, Kumar
A
, Saran
RK
. Celiac disease and Helicobacter pylori infection in children: is there any association?
J Gastroenterol Hepatol
. 2017
;32
(6
):1178
–82
. .20.
Luzza
F
, Mancuso
M
, Imeneo
M
, Mesuraca
L
, Contaldo
A
, Giancotti
L
, Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathologic features
. J Pediatr Gastroenterol Nutr
. 1999
;28
(2
):143
–6
. .21.
Konturek
PC
, Karczewska
E
, Dieterich
W
, Hahn
EG
, Schuppan
D
. Increased prevalence of Helicobacter pylori infection in patients with celiac disease
. Am J Gastroenterol
. 2000
;95
(12
):3682
–3
. .22.
Dore
MP
, Bilotta
M
, Malaty
HM
, Pacifico
A
, Maioli
M
, Graham
DY
, Diabetes mellitus and Helicobacter pylori infection
. Nutrition
. 2000
;16
(6
):407
–10
. .23.
Tada
A
, Komiya
N
, Shimada
A
, Katsuki
T
, Oikawa
Y
, Itoh
H
. Eradication of Helicobactor pylori may trigger onset of type 1 diabetes: a case report
. Ann N Y Acad Sci
. 2008
;1150
:208
–9
. .24.
Arslan
D
, Kendirci
M
, Kurtoglu
S
, Kula
M
. Helicobacter pylori infection in children with insulin dependent diabetes mellitus
. J Pediatr Endocrinol Metab
. 2000
;13
(5
):553
–6
. .25.
Coker
M
, Can
S
, Darcan
S
, Orbak
Z
, Aydoğdu
S
, Yagci
RV
. Helicobacter pylori seropositivity in children with diabetes mellitus type 1
. J Trop Pediatr
. 2001
;47
(2
):123
–4
. .26.
Candelli
M
, Rigante
D
, Schiavino
A
, Gabrielli
M
, Crea
F
, Minguell Del Lungo
L
, High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study
. Eur Rev Med Pharmacol Sci
. 2012
;16
(11
):1468
–72
.27.
Zekry
OA
, Abd Elwahid
HA
. The association between Helicobacter pylori infection, type 1 diabetes mellitus, and autoimmune thyroiditis
. J Egypt Public Health Assoc
. 2013
;88
(3
):143
–7
. .28.
Bazmamoun
H
, Rafeey
M
, Nikpouri
M
, Ghergherehchi
R
. Helicobacter pylori infection in children with type 1 diabetes mellitus: a case-control study
. J Res Health Sci
. 2016
;16
(2
):68
–71
.29.
Khalifa
MM
, Sharaf
RR
, Aziz
RK
. Helicobacter pylori: a poor man’s gut pathogen?
Gut Pathogens
. 2010
;2
:2
.30.
Strachan
DP
. Hay fever, hygiene, and household size
. BMJ
. 1989
;299
(6710
):1259
–60
. .31.
Lionetti
E
, Catassi
C
. New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment
. Int Rev Immunol
. 2011
;30
(4
):219
–31
. .32.
Caron
TJ
, Scott
KE
, Fox
JG
, Hagen
SJ
. Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier
. World J Gastroenterol
. 2015
;21
(40
):11411
–27
. .33.
Jones
NL
, Koletzko
S
, Goodman
K
, Bontems
P
, Cadranel
S
, Casswall
T
, ; ESPGHAN, NASPGHAN
. Joint ESPGHAN/NASPGHAN guidelines for the management of helicobacter pylori in children and adolescents (Update 2016)
. J Pediatr Gastroenterol Nutr
. 2017
;64
:991
–1003
.34.
Kalaycioğlu
S
, Çelik
K
, Çelen
Ü
, Türkyilmaz
S
. Developing A Tool For The Measurement Of Socio-Economic Status (SES) From A Representative Sample:The Case Of Ankara City Center
. JSR
. 2010
;13
:182
–220
.35.
WHO, UNICEF, UNU. IDA: Prevention, Assessment and Control. Report of a joint WHO/UNICEF/UNU consultation. World Health Organization, Geneva, 1998.
36.
Oberhuber
G
, Caspary
WF
, Kirchner
T
, Borchard
F
, Stolte
M
; German Society for Pathology Task Force on Gastroenterologic Pathology
. Diagnosis of celiac disease and sprue. Recommendations of the German society for pathology task force on gastroenterologic pathology
. Pathologe
. 2001
;22
:72
–81
.37.
Dixon
MF
, Genta
RM
, Yardley
JH
, Correa
P
. Classification and grading of gastritis. The updated Sydney system
. Am J Surg Pathol
. 1996
;20
:1161
–81
.38.
Horikawa
C
, Kodama
S
, Fujihara
K
, Yachi
Y
, Tanaka
S
, Suzuki
A
, Association of Helicobacter pylori infection with glycemic control in patients with diabetes: a meta-analysis
. J Diabetes Res
. 2014
;2014
:250620
. .39.
Dai
YN
, Yu
WL
, Zhu
HT
, Ding
JX
, Yu
CH
, Li
YM
. Is Helicobacter pylori infection associated with glycemic control in diabetics?
World J Gastroenterol
. 2015
;21
(17
):5407
–16
. .40.
Chen
J
, Xing
Y
, Zhao
L
, Ma
H
. The association between Helicobacter pylori Infection and glycated hemoglobin a in diabetes: a meta-analysis
. J Diabetes Res
. 2019
;2019
:3705264
. .41.
Ertem
D
, Harmanci
H
, Pehlivanoğlu
E
. Helicobacter pylori infection in Turkish preschool and school children: role of socioeconomic factors and breast feeding
. Turk J Pediatr
. 2003
;45
(2
):114
–22
.42.
Pérez-Rodríguez
M
, Partida-Rodríguez
O
, Camorlinga-Ponce
M
, Flores-Luna
L
, Lazcano
E
, Gómez
A
, Polymorphisms in HLA-DQ genes, together with age, sex, and Helicobacter pylori infection, as potential biomarkers for the early diagnosis of gastric cancer
. Helicobacter
. 2017
;22
(1
):e12326
. .43.
Wang
J
, Zhang
Q
, Liu
Y
, Han
J
, Ma
X
, Luo
Y
, Association between HLA-II gene polymorphism and Helicobacter pylori infection in Asian and European population: a meta-analysis
. Microb Pathog
. 2015
;82
:15
–26
.44.
Dore
MP
, Salis
R
, Loria
MF
, Villanacci
V
, Bassotti
G
, Pes
GM
. Helicobacter pylori infection and occurrence of celiac disease in subject’s HLA-DQ2/DQ8 positive: A prospective study
. Helicobacter
. 2018
;23
:e12465
.45.
Krupica
T
Jr, Fry
TJ
, Mackall
CL
. Autoimmunity during lymphopenia: a two-hit model
. Clin Immunol
. 2006
;120
(2
):121
–8
. .46.
Bollyky
JB
, Xu
P
, Butte
AJ
, Wilson
DM
, Beam
CA
, Greenbaum
CJ
. Type 1 diabetes trialnet study group. Heterogeneity in recent-onset type 1 diabetes: a clinical trial perspective
. Diabetes Metab Res Rev
. 2015
;31
:588
–94
.47.
Di Sabatino
A
, D’Alò
S
, Millimaggi
D
, Ciccocioppo
R
, Parroni
R
, Sciarra
G
, Apoptosis and peripheral blood lymphocyte depletion in coeliac disease
. Immunology
. 2001
;103
(4
):435
–40
. .48.
Li
X
, Atkinson
MA
. The role for gut permeability in the pathogenesis of type 1 diabetes: a solid or leaky concept?
Pediatr Diabetes
. 2015
;16
(7
):485
–92
. .49.
Sapone
A
, Lammers
KM
, Casolaro
V
, Cammarota
M
, Giuliano
MT
, De Rosa
M
, Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity
. BMC Med
. 2011
;9
:23
. .50.
Villanacci
V
, Bassotti
G
, Liserre
B
, Lanzini
A
, Lanzarotto
F
, Genta
RM
. Helicobacter pylori infection in patients with celiac disease
. Am J Gastroenterol
. 2006
;101
(8
):1880
–5
. .51.
Simondi
D
, Ribaldone
DG
, Bonagura
GA
, Foi
S
, Sapone
N
, Garavagno
M
, Helicobacter pylori in celiac disease and in duodenal intraepithelial lymphocytosis: active protagonist or innocent bystander?
Clin Res Hepatol Gastroenterol
. 2015
;39
(6
):740
–5
. .52.
Maxim
R
, Pleşa
A
, Stanciu
C
, Girleanu
I
, Moraru
E
, Trifan
A
. Helicobacter pylori prevalence and risk factors among children with celiac disease
. Turk J Gastroenterol
. 2019
;30
(3
):284
–9
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
